Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-24-263737
Filing Date
2024-11-22
Accepted
2024-11-22 06:04:03
Documents
17
Period of Report
2024-11-19
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d888761d8ka.htm   iXBRL 8-K/A 45321
2 EX-16.1 d888761dex161.htm EX-16.1 21561
7 GRAPHIC g888761dsp7.jpg GRAPHIC 7420
8 GRAPHIC g888761dsp9.jpg GRAPHIC 7508
  Complete submission text file 0001193125-24-263737.txt   266421

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sclxw-20241119.xsd EX-101.SCH 4468
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sclxw-20241119_def.xml EX-101.DEF 14279
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sclxw-20241119_lab.xml EX-101.LAB 23933
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sclxw-20241119_pre.xml EX-101.PRE 15313
20 EXTRACTED XBRL INSTANCE DOCUMENT d888761d8ka_htm.xml XML 7392
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39852 | Film No.: 241486284
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)